» Articles » PMID: 24595492

Histopathological Evidence of Invasive Gastric Mucormycosis After Transarterial Chemoembolization and Liver Transplantation

Overview
Journal Infection
Date 2014 Mar 6
PMID 24595492
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We describe a case of a 62-year-old diabetic woman with hepatocellular carcinoma due to chronic hepatitis B virus infection. Two weeks after orthotopic liver transplantation, endoscopy for massive upper gastrointestinal bleeding revealed a large necrotic area in the gastric fundus. The patient underwent emergency resection. Histopathologically, angioinvasive mold infection compatible with mucormycosis was diagnosed in a large area of necrosis, mimicking an atypically localized gastric ulcer. Foreign bodies originating from transarterial chemoembolization (TACE) performed 7 and 8 months earlier and 40 days before transplantation were identified in the submucosal tissue. The patient was treated with liposomal amphotericin B (LAB) for 5 weeks, followed by 7 weeks of posaconazole. Follow-up biopsies after 1 and 5 months confirmed successful treatment. Review of the radiological images of the TACE procedure showed that some of the TACE material had been diverted to the stomach via an accessory gastric branch originating from the left hepatic artery. TACE agents may be associated with chronic, refractory gastroduodenal ulcers. We hypothesize that the ischemic lesion was first colonized with presumed Mucorales mold and invasive growth was promoted by the posttransplantation immunosuppression. Careful exploration of extrahepatic collaterals during TACE may prevent this complication.

Citing Articles

Idiopathic gastric fundus necrosis: Case report about a rare and fatal clinical condition.

Tognoni V, Gazia C, Ivanikhin A, Pathirannehalage Don C, Venditti D Int J Surg Case Rep. 2020; 70:168-171.

PMID: 32417732 PMC: 7229420. DOI: 10.1016/j.ijscr.2020.04.023.


Gastric mucormycosis complicated by a gastropleural fistula: A case report and review of the literature.

Uchida T, Okamoto M, Fujikawa K, Yoshikawa D, Mizokami A, Mihara T Medicine (Baltimore). 2019; 98(48):e18142.

PMID: 31770250 PMC: 6890297. DOI: 10.1097/MD.0000000000018142.

References
1.
Skiada A, Pagano L, Groll A, Zimmerli S, DuPont B, Lagrou K . Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011; 17(12):1859-67. DOI: 10.1111/j.1469-0691.2010.03456.x. View

2.
Park B, Pappas P, Wannemuehler K, Alexander B, Anaissie E, Andes D . Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis. 2011; 17(10):1855-64. PMC: 3311117. DOI: 10.3201/eid1710.110087. View

3.
Cornely O, Arikan-Akdagli S, Dannaoui E, Groll A, Lagrou K, Chakrabarti A . ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014; 20 Suppl 3:5-26. DOI: 10.1111/1469-0691.12371. View

4.
Thomson S, Bade P, Taams M, Chrystal V . Gastrointestinal mucormycosis. Br J Surg. 1991; 78(8):952-4. DOI: 10.1002/bjs.1800780819. View

5.
Chamilos G, Lewis R, Kontoyiannis D . Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008; 47(4):503-9. DOI: 10.1086/590004. View